Indian pharma stocks, including Sun Pharma and Aurobindo Pharma, are in focus after the US exempted India and 19 other ...

Sun Pharma has entered an exclusive agreement with LIB Therapeutics to commercialise Lerodalcibep across markets outside the US and China, gaining access to a US$ 3.7 billion PCSK9 market.

Sun Pharma will commercialise and manufacture LIB Therapeutics' once-monthly cholesterol drug outside the US and China after ...

Sun Pharma will be responsible for pursuing regulatory approvals in licensed territories where approval has not yet been ...

Sun Pharma will be responsible for pursuing regulatory approvals in licensed territories where approval has not yet been obtained. The excluded China territory comprises mainland China, Hong Kong, ...

Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715; together with its subsidiaries and/or associated companies, "Sun Pharma") and LIB Therapeutics ...

Sun Pharma Advanced Research Company Limited is an India-based clinical-stage biopharmaceutical company that focuses on developing therapeutics to improve standards of care for pa ...

Sun Pharmaceutical Industries Ltd. 524715 +1.77% shares advanced 1.77% to 1,868.00 Indian rupees Monday, on what proved to be an all-around favorable trading session for the stock market, with the BSE ...

Sun Pharma is teaming up with fashion designer Christian Siriano for a new educational campaign focused on the positives of ...

Sun Pharmaceutical Industries Limited has announced an exclusive licensing, commercialization, and manufacturing agreement ...

Sun Pharma inks exclusive licensing with LIB Therapeutics to commercialize lerodalcibep worldwide (excluding U.S. and China) ...

Lerodalcibep is approved in the EU under the brand name Lyrokaul for the treatment of adult patients with ...